You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
With Hi-C mapping, FISH imaging insights, and other approaches, researchers identified genome organization plasticity and between-allele variability.
With long-read sequencing, mapping, and other approaches, researchers assembled a high-quality genome for Aedes aegypti, a notorious infectious disease vector.
The researchers say that methods that include gene expression as well as other genomic data in one assay could help unravel cell function and gene regulation.
The company's offering of 3.36 million units at $6.125 per unit — each consisting of one share of common stock and one warrant — is expected to close Aug. 23.
Genoox and Bionano will both sell and market the integrated platform for research and future clinical applications.
Using sequenced strains of more than 1,000 S. cerevisiae fromaround the world, the team found that the yeast species originated in China.
At PAG, researchers from the Rockefeller University Vertebrate Genome Laboratory outlined sequencing and assembly strategies for phase 1 of the VGP G10K.
As long-read sequencing and genome mapping technologies improve, researchers have begun using them in the clinic to identify once undetectable structural variants.
The technology could analyze, in one assay, all structural variants known to be diagnostic and prognostic for blood cancers, potentially replacing serial FISH testing.
The Brown University spinout plans to market its instrument, Nabsys HD-Mapping, for genome mapping, de novo assembly, and structural variant detection.
In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.
Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.
The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.
The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.